Ischemic heart disease decisions — 2025

The Board denied service connection for ischemic heart disease and diabetes mellitus type II, finding no evidence of in-service exposure to herbicide agents.

The Board remands the issue of entitlement to service connection for a heart disability due to an inadequate VA medical opinion and the need for a TERA medical opinion under the PACT Act.

The Board denied service connection for hypertension, coronary artery disease, congestive heart failure, carotid artery disease blockage with surgery, peripheral arterial disease, prostate cancer, bladder cancer, kidney cancer, and anxiety and depression as not being related to the Veteran's active duty or any herbicide exposure.

The Board denied service connection for coronary artery disease, posttraumatic stress disorder, and a cervical spine disability. A 40 percent rating was granted for radiculopathy of the left lower extremity.

The Board granted a 30 percent rating for diabetic peripheral neuropathy in the left and right lower extremities but denied higher ratings for diabetic nephropathy, diabetes mellitus type II, and other claims.

The Board denied the Veteran's claim for a TDIU prior to January 31, 2019, as his service-connected disabilities did not render him unable to secure and follow substantially gainful employment.

The Board granted service connection for coronary artery disease, diabetes mellitus type 2, bilateral lower extremity peripheral neuropathy (secondary to diabetes), sleep apnea, and a back disability.

The appeal was dismissed due to the Veteran's death during its pendency.

The Board granted a rating of 10 percent for hypertension and denied ratings in excess of 30 percent prior to June 7, 2021, and in excess of 60 percent thereafter for hypertensive heart disease.

The Board granted increased ratings for neuropathy of the right and left lower sciatic nerves, but denied service connection for bilateral hearing loss, depleted lung function, hypertension, blurred vision, and coronary artery disease.

The Board denied service connection for a lumbar disability and denied increased ratings for various disabilities, except for granting a 60 percent rating for coronary artery disease and a 50 percent rating for PTSD.

The Board granted a 30 percent rating for the Veteran's service-connected myocardial infarction with stents and coronary artery bypass graft, effective June 1, 2022, but denied restoration of a 60 percent rating.

The Board remands the claim for a new opinion to address whether the Veteran's heart disability, including his bicuspid aortic valve, was aggravated by service or is related to in-service toxic exposure.

The Board remands the claims for service connection for hypertension and a heart disability to correct an examiner's failure to render an adequate opinion.

The Board granted service connection for a heart condition and a cervical spine condition, but remanded the claim for a bilateral foot condition for further development.

The Board granted service connection for degenerative arthritis of the thoracolumbar spine, finding it related to an in-service injury. The heart condition issue was remanded for further development.

The Veteran's ischemic heart disease (IHD), status post myocardial infraction (MI) was rated at 60 percent from September 1, 2014, but a rating in excess of 60 percent for the period from May 24, 2023 to November 5, 2023 was denied.

The Board remands the issues of ratings in excess of 60 percent for diabetes mellitus, type II, from April 8, 2024; in excess of 20 percent for diabetes mellitus, type II, from October 17, 2013, to April 8, 2024; and special monthly compensation (SMC) under 38 U.S.C. � 1114(s), based upon housebound status prior to October 17, 2013.

The appeals for service connection for an acquired psychiatric disability, residuals of a stab wound to the back, spleen disability, liver disability, and heart disability are dismissed due to untimely filings.

Service connection for the Veteran's cause of death, due to ischemic heart disease and coronary heart disease, is granted based on presumed exposure to herbicides during service at U-Tapao RTAFB in Thailand.